Home › Lung Diseases › Illinois › Evanston
Lung Diseases clinical trials in Evanston, IL
3 studies for Lung Diseases are looking for participants at sites in and around Evanston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RecruitingPhase 3
- Research Site, Evanston
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RecruitingPhase 3
- Endeavor Health Evanston Hospital, Evanston
- Endeavor Health Clinical Trials Center, Skokie · 2 mi away
- Endeavor Health Immediate Care - Old Orchard, Skokie · 2 mi away
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RecruitingPhase 2
- Advocate Aurora Health, Park Ridge · 8 mi away
About Lung Diseases
Lung diseases are disorders or infections that affect the lungs and cause breathing problems. Some can lead to respiratory failure. Find out more about prevention, living with lung diseases, and treatment.
More about Lung Diseases on MedlinePlus
Lung Diseases trials in other cities
- Houston, TX16 studies
- Boston, MA14 studies
- Durham, NC13 studies
- New York City, NY13 studies
- Pittsburgh, PA11 studies
- Dallas, TX10 studies
- Los Angeles, CA10 studies
- Ann Arbor, MI10 studies
- Miami, FL10 studies
- Columbus, OH10 studies
- Chicago, IL9 studies
- Washington, DC9 studies
Other studies in Evanston
- Non-Small Cell Lung Cancer21 studies
- Lung Cancer19 studies
- Breast Cancer13 studies
- Acute Myeloid Leukemia11 studies
- Prostate Cancer10 studies
- Obesity10 studies
- Colorectal Cancer10 studies
- Cancer (all types)9 studies
- Ulcerative Colitis9 studies
- Overweight9 studies
- Crohn's Disease9 studies
- Atrial Fibrillation8 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.